| Title |
Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
|
|---|---|
| Published in |
Molecular Cancer Therapeutics, February 2011
|
| DOI | 10.1158/1535-7163.mct-10-0750 |
| Pubmed ID | |
| Authors |
Noriaki Sunaga, David S. Shames, Luc Girard, Michael Peyton, Jill E. Larsen, Hisao Imai, Junichi Soh, Mitsuo Sato, Noriko Yanagitani, Kyoichi Kaira, Yang Xie, Adi F. Gazdar, Masatomo Mori, John D. Minna |
Mendeley readers
The data shown below were compiled from readership statistics for 196 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Denmark | 2 | 1% |
| United Kingdom | 1 | <1% |
| Switzerland | 1 | <1% |
| Argentina | 1 | <1% |
| Unknown | 189 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 49 | 25% |
| Student > Ph. D. Student | 44 | 22% |
| Student > Bachelor | 21 | 11% |
| Student > Master | 17 | 9% |
| Other | 13 | 7% |
| Other | 29 | 15% |
| Unknown | 23 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 61 | 31% |
| Biochemistry, Genetics and Molecular Biology | 46 | 23% |
| Medicine and Dentistry | 34 | 17% |
| Chemistry | 12 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Other | 12 | 6% |
| Unknown | 25 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#7,730,009
of 23,509,253 outputs
Outputs from Molecular Cancer Therapeutics
#1,717
of 3,916 outputs
Outputs of similar age
#56,499
of 186,914 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#20
of 29 outputs
Altmetric has tracked 23,509,253 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,916 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,914 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.